Condition: Multiple Sclerosis · Sponsor: Brain Health Alliance
To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.
This description comes directly from the study's public registry record.
Carl Taswell, MD, PhD · 949-481-3121 · ctaswell@brainhealthalliance.org
Always discuss trial participation with your own doctor first.
| Brain Health Alliance | Ladera Ranch, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04390009